Literature DB >> 12836072

Functional recovery after simultaneous transplantation with neuro-epithelial stem cells and adjacent mesenchymal tissues into infarcted rat brain.

A Fukunaga1, T Kawase, K Uchida.   

Abstract

BACKGROUND: Cerebral infarction results in impairment of motor and cognitive functions. We performed intracranial transplantation of multipotential neuro-epithelial stem cells with mesenchyme into experimentally large ischemic lesions to study their potential to relieve deficits.
METHODS: Wistar albino rats were subjected to transient middle cerebral artery occlusion for 60 minutes, producing an extensive ischemic lesion in the ipsilateral striatum and adjacent cerebral cortex. The rat mesencephalic neural plate at the early somite stage (embryonic day 10.5) together with adjacent ventral mesenchyme was used as donor material. We performed histological and immunohistochemical studies, with antibodies against tyrosine hydroxylase, and dopamine- and adenosine 3': 5'-monophosphate-regulated phosphoprotein 32 (DARPP-32; a striatal marker). Micro-angiograms were made by using Microfil silicone rubber. Morris Water-maze learning and treadmill task were employed to evaluate motor and cognitive functions.
FINDINGS: A viable non-tumoral mass was recognized in the rat striatum, up to as long as 156 days after transplantation. There were many cells positive for tyrosine hydroxylase or DARPP-32 in the graft. Some of the DARPP-32 positive cells within the graft had extended their dendrites into host tissues. In the micro-angiograms, many fine vessels were observed within the graft and dilated vessels meandered around the graft. Transplanted animals recovered significantly better in motor and cognitive functions than animals injected with only culture medium.
INTERPRETATION: Neuro-epithelial stem cells may follow several lines of differentiation; along the naturally genetically programmed line of differentiation, or along other cell lines depending on different environments. Grafting of neuro-epithelial stem cells with mesenchyme may merit a further study as a treatment for cerebral infarction.

Entities:  

Mesh:

Year:  2003        PMID: 12836072     DOI: 10.1007/s00701-003-0038-x

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  5 in total

1.  Tracking stem cell differentiation in the setting of automated optogenetic stimulation.

Authors:  Albrecht Stroh; Hsing-Chen Tsai; Li-Ping Wang; Feng Zhang; Jenny Kressel; Alexander Aravanis; Nandhini Santhanam; Karl Deisseroth; Arthur Konnerth; M Bret Schneider
Journal:  Stem Cells       Date:  2011-01       Impact factor: 6.277

2.  Pinealon protects the rat offspring from prenatal hyperhomocysteinemia.

Authors:  Alexander Arutjunyan; Lyudmila Kozina; Sergey Stvolinskiy; Yelena Bulygina; Anna Mashkina; Vladimir Khavinson
Journal:  Int J Clin Exp Med       Date:  2012-04-06

3.  Cerebrovascular casting of the adult mouse for 3D imaging and morphological analysis.

Authors:  Espen J Walker; Fanxia Shen; William L Young; Hua Su
Journal:  J Vis Exp       Date:  2011-11-30       Impact factor: 1.355

4.  Intravenous grafts of amniotic fluid-derived stem cells induce endogenous cell proliferation and attenuate behavioral deficits in ischemic stroke rats.

Authors:  Naoki Tajiri; Sandra Acosta; Loren E Glover; Paula C Bickford; Alejandra Jacotte Simancas; Takao Yasuhara; Isao Date; Marianna A Solomita; Ivana Antonucci; Liborio Stuppia; Yuji Kaneko; Cesar V Borlongan
Journal:  PLoS One       Date:  2012-08-17       Impact factor: 3.240

Review 5.  Therapeutic outcomes of transplantation of amniotic fluid-derived stem cells in experimental ischemic stroke.

Authors:  Naoki Tajiri; Sandra Acosta; Gabriel S Portillo-Gonzales; Daniela Aguirre; Stephanny Reyes; Diego Lozano; Mibel Pabon; Ike Dela Peña; Xunming Ji; Takao Yasuhara; Isao Date; Marianna A Solomita; Ivana Antonucci; Liborio Stuppia; Yuji Kaneko; Cesar V Borlongan
Journal:  Front Cell Neurosci       Date:  2014-08-13       Impact factor: 5.505

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.